Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 2
1989 1
1990 1
1991 3
1992 2
1993 2
1994 5
1995 3
1996 3
1997 5
1998 2
1999 4
2000 5
2001 6
2002 8
2003 11
2004 14
2005 10
2006 21
2007 9
2008 15
2009 17
2010 22
2011 23
2012 33
2013 26
2014 39
2015 29
2016 42
2017 43
2018 49
2019 55
2020 58
Text availability
Article attribute
Article type
Publication date

Search Results

519 results
Results by year
Filters applied: . Clear all
Page 1
[CA19-9 in intrahepatic cholangiocarcinoma : A diagnostic and prognostic armamentarium?].
Juntermanns B, Kaiser GM, Itani Gutierrez S, Heuer M, Buechter M, Kahraman A, Reis H, Kasper S, Paul A, Fingas CD. Juntermanns B, et al. Chirurg. 2018 Jun;89(6):466-471. doi: 10.1007/s00104-018-0636-z. Chirurg. 2018. PMID: 29644426 German.
The role of CA19-9 in terms of patient prognosis is still under debate in the literature. OBJECTIVE: The aim of the present study was to investigate the prognostic value of preoperatively assessed CA19-9 levels in patients with intrahepatic cholangi
The role of CA19-9 in terms of patient prognosis is still under debate in the literature. OBJECTIVE: The aim of the present st …
Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Rizvi S, Gores GJ. Rizvi S, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar CCA (pCCA), or distal CCA. ...
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomica
[Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
Tang X, Zhang J, Chen Y, Lan Z, Wang C. Tang X, et al. Zhonghua Zhong Liu Za Zhi. 2014 Sep;36(9):662-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25564055 Chinese.
OBJECTIVE: To study the correlation between clinicopathological features and serum carbohydrate antigen 19-9 (CA19-9)/carcinoembryonic antigen (CEA) in patients with extrahepatic cholangiocarcinoma (ECC). ...RESULTS: The average va …
OBJECTIVE: To study the correlation between clinicopathological features and serum carbohydrate antigen 19-9 (CA19
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.
Bergquist JR, Ivanics T, Storlie CB, Groeschl RT, Tee MC, Habermann EB, Smoot RL, Kendrick ML, Farnell MB, Roberts LR, Gores GJ, Nagorney DM, Truty MJ. Bergquist JR, et al. J Surg Oncol. 2016 Sep;114(4):475-82. doi: 10.1002/jso.24381. Epub 2016 Jul 20. J Surg Oncol. 2016. PMID: 27439662 Free PMC article.
BACKGROUND: Optimal management of patients with intrahepatic cholangiocarcinoma (ICCA) and elevated CA19-9 remains undefined. We hypothesized CA19-9 elevation above normal indicates aggressive biology and that inclusion of CA19-9 w …
BACKGROUND: Optimal management of patients with intrahepatic cholangiocarcinoma (ICCA) and elevated CA19-9 remains unde …
MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G, Liu X, Wu D, Duan F, Xie X, Wen S, Li Y, Li S. Liao G, et al. Aging (Albany NY). 2019 Jun 9;11(11):3639-3649. doi: 10.18632/aging.102003. Aging (Albany NY). 2019. PMID: 31180332 Free PMC article.
However, its role in cholangiocarcinoma (CCA) remains largely unknown. The aim of this study was to investigate the expression profile of MORC2 and its potential functions in CCA progression. ...MORC2 expression was significantly associated with serum CA19-9
However, its role in cholangiocarcinoma (CCA) remains largely unknown. The aim of this study was to investigate the expression profil …
The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma.
Moro A, Mehta R, Sahara K, Tsilimigras DI, Paredes AZ, Farooq A, Hyer JM, Endo I, Shen F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Soubrane O, Koerkamp BG, Sasaki K, Pawlik TM. Moro A, et al. Ann Surg Oncol. 2020 Aug;27(8):2888-2901. doi: 10.1245/s10434-020-08350-8. Epub 2020 Mar 20. Ann Surg Oncol. 2020. PMID: 32198569
BACKGROUND: The objective of the current study was to assess the impact of serum CA19-9 and CEA and their combination on survival among patients undergoing surgery for intrahepatic cholangiocarcinoma (ICC). ...RESULTS: Among 588 patients, 5-year OS was consid …
BACKGROUND: The objective of the current study was to assess the impact of serum CA19-9 and CEA and their combination on survi …
Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.
Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Qin XL, et al. World J Gastroenterol. 2004 Feb 1;10(3):427-32. doi: 10.3748/wjg.v10.i3.427. World J Gastroenterol. 2004. PMID: 14760772 Free PMC article.
The aims of our study were to evaluate the usefulness of a serum CA19-9 determination in the diagnosis of cholangiocarcinoma. ...In patients with cholangiocarcinoma, however, no correlation was found between serum CEA and CA19-9 concentra …
The aims of our study were to evaluate the usefulness of a serum CA19-9 determination in the diagnosis of cholangiocarcinom
Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Liang B, Zhong L, He Q, Wang S, Pan Z, Wang T, Zhao Y. Liang B, et al. Med Sci Monit. 2015 Nov 18;21:3555-63. doi: 10.12659/msm.895040. Med Sci Monit. 2015. PMID: 26576628 Free PMC article. Review.
BACKGROUND Cholangiocarcinoma (CCA) is a relatively rare cancer worldwide; however, its incidence is extremely high in Asia. Numerous studies reported that serum carbohydrate antigen 19-9 (CA19-9) plays a role in the diagnosis of CCA pati …
BACKGROUND Cholangiocarcinoma (CCA) is a relatively rare cancer worldwide; however, its incidence is extremely high in Asia. Numerous …
Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.
Nakamoto S, Kumamoto Y, Igarashi K, Fujiyama Y, Nishizawa N, Ei S, Tajima H, Kaizu T, Watanabe M, Yamashita K. Nakamoto S, et al. PLoS One. 2018 Oct 16;13(10):e0205864. doi: 10.1371/journal.pone.0205864. eCollection 2018. PLoS One. 2018. PMID: 30325974 Free PMC article.
Multivariate analysis identified that CDO1 hypermethylation, preoperative serum CA19-9 and perineural invasion were independent prognostic factors in EHCC. ...The combination of CDO1 methylation and preoperative serum CA19-9 effectively enriched EHCC p …
Multivariate analysis identified that CDO1 hypermethylation, preoperative serum CA19-9 and perineural invasion were independen …
[The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma].
Zong D, Zeng Y. Zong D, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Sep;45(5):819-22. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 25341348 Chinese.
OBJECTIVE: To evaluate the predictability of preoperative serum Carbonhydrate antigen (CA19-9) and Carcino-embryonic antigen (CEA) for tumor resectability in the patients with hilar cholangiocarcinoma (HC). ...CONCLUSION: The HC patients with " …
OBJECTIVE: To evaluate the predictability of preoperative serum Carbonhydrate antigen (CA19-9) and Carcino-embryonic …
519 results
Jump to page
Feedback